Md. Tingle et al., COMPARISON OF THE METABOLISM AND TOXICITY OF DAPSONE IN RAT, MOUSE AND MAN, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 817-823
The metabolism and toxicity of dapsone was compared in vitro and in vi
vo in rat, mouse and man. Metabolism was assessed by high-pressure liq
uid chromatography-mass spectrometry and methemoglobin formation has b
een used as a toxic endpoint. The greatest toxicity in vitro was seen
in microsomes prepared from male Wistar rats (36.6 +/- 1.5% methemoglo
bin), although toxicity was also seen in microsomes from the female ra
t (8.2 +/- 1.3%), male CD1 (4.2 +/- 1.6%) and human (10.9 +/- 1.1%). T
he rank order of toxicity agreed with the formation of the hydroxylami
ne metabolite in vitro. All microsomes were also capable of catalyzing
the reverse reaction, i.e., reduction of the hydroxylamine to dapsone
. However, in vivo administration of dapsone resulted in significant (
P < 0.05) methemoglobinemia only in male rats and humans. This species
difference in the susceptibility to dapsone toxicity could not be att
ributed solely to the sensitivity of the target erythrocytes, because
the order of sensitivity to dapsone hydroxylamine was human > mouse >
rat. Analysis of bile and urine revealed the formation of dapsone hydr
oxylamine and its glucuronide in male rats and humans, but not in fema
le rats or mice. This species difference in the metabolism and toxicit
y of dapsone has important implications in the safety evaluation of re
lated compounds for man.